Yue Ting, Chen Bing-Hua, Wu Lian-Ming, Xu Jian-Rong, Pu Jun
Department of Radiology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Department of Cardiology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
J Magn Reson Imaging. 2020 May;51(5):1422-1439. doi: 10.1002/jmri.26982. Epub 2019 Nov 11.
The presence of late gadolinium enhanced (LGE), which may enable better evaluation of myocardial impairment, would help predict the occurrence of life-threatening arrhythmias and major adverse cardiovascular events (MACE) in patients suffering from ischemic cardiomyopathy (ICM) and nonischemic cardiomyopathy (NICM) patients and who underwent a process of implantable cardioverter-defibrillator (ICD).
To evaluate the prognostic value of cardiac MR-LGE for ICM and NICM patients with ICD.
Systematic review and meta-analysis.
A total of 33 studies of 3457 patients were included.
PubMed, Cochrane Library, EMBASE, and Web of Science were systematically searched for studies reporting LGE in ICM or NICM patients with ICD implantation with several kinds of endpoints: MACE, life-threatening arrhythmia, cardiovascular mortality, and all-cause mortality.
A meta-analysis was performed using a random-effects model to calculate odds ratios or standard mean differences (SMDs) for binary and continuous data.
MR-LGE was positive in 1923 (55.6%) of ICM and NICM patients. LGE-present patients were more likely to have life-threatening arrhythmia (odds ratio [OR]: 5.1; 95% confidence interval [CI]: 3.8-6.8), MACE (OR: 5.2; 95% CI: 3.8-6.9), cardiovascular mortality (OR: 2.4; 95% CI: 1.2-4.6), and all-cause mortality (OR: 2.1; 95% CI: 1.3-3.4) compared with those without LGE. Moreover, ICM and NICM patients with LGE both had increased life-threatening arrhythmia (OR: 4.6; 95% CI: 2.7-8.0; OR: 5.2; 95% CI: 3.6-7.8, respectively) and MACE (OR: 4.7; 95% CI: 2.8-7.9; OR: 4.7; 95% CI: 2.7-8.1, respectively).
The presence of MR-LGE may worsen the prognosis for adverse cardiovascular events in both ICM and NIMC patients who benefit more from ICDs.
3 Technical Efficacy Stage: 3 J. Magn. Reson. Imaging 2020;51:1422-1439.
延迟钆增强(LGE)的存在有助于更好地评估心肌损伤,这将有助于预测缺血性心肌病(ICM)和非缺血性心肌病(NICM)患者以及接受植入式心脏复律除颤器(ICD)治疗的患者发生危及生命的心律失常和主要不良心血管事件(MACE)的情况。
评估心脏磁共振延迟钆增强(MR-LGE)对植入ICD的ICM和NICM患者的预后价值。
系统评价和荟萃分析。
共纳入33项研究,涉及3457例患者。
1.5T和3.0T,LGE。
系统检索PubMed、Cochrane图书馆、EMBASE和科学网,查找报告植入ICD的ICM或NICM患者LGE情况的研究,研究终点包括:MACE、危及生命的心律失常、心血管死亡率和全因死亡率。
采用随机效应模型进行荟萃分析以计算二分类和连续性数据的比值比或标准化均数差(SMD)。
ICM和NICM患者中1923例(55.6%)MR-LGE呈阳性。与无LGE的患者相比,存在LGE的患者更易发生危及生命的心律失常(比值比[OR]:5.1;95%置信区间[CI]:3.8 - 6.8)、MACE(OR:5.2;95% CI:3.8 - 6.9)、心血管死亡率(OR:2.4;95% CI:1.2 - 4.6)和全因死亡率(OR:2.1;95% CI:1.3 - 3.4)。此外,ICM和NICM有LGE的患者发生危及生命的心律失常(OR分别为:4.6;95% CI:2.7 - 8.0;OR:5.2;95% CI:3.6 - 7.8)和MACE(OR分别为:4.7;95% CI:2.8 - 7.9;OR:4.7;95% CI:2.7 - 8.1)的可能性均增加。
MR-LGE的存在可能会使从ICD中获益更多的ICM和NIMC患者发生不良心血管事件的预后变差。
3级 技术效能阶段:3级 《磁共振成像杂志》2020年;51:1422 - 1439。